Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform

Introduction: Patients with advanced-stage non-small cell lung cancer (NSCLC) may benefit from a short time-to-treatment (TTT). Predictive biomarker testing is performed prior to treatment, as recommended by various international expert consensus bodies. Genetic testing is more time-intensive than i...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Norbert Banyi, Deepu Alex, Curtis Hughesman, Kelly McNeil, Diana N. Ionescu, Carmen Ma, Stephen Yip, Barbara Melosky
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-10-01
Schriftenreihe:	Current Oncology
Schlagworte:	EGFR testing time-to-treatment non-small cell lung cancer genetic testing lung molecular biomarkers
Online-Zugang:	https://www.mdpi.com/1718-7729/29/10/624
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!